medline.ch Onkologie Urologische Tumoren

	PSMA expression: enhancing prostate cancer diagnosis at the biopsy stage. Minerva Urol Nephrol Leonardi R, Mazza M, Nicolini F, Borges DE Souza P, Lupo A, DI Dio M, Calarco A, Mantica G, Ambrosini F, Pegreffi F, Paganelli G, Puccetti M, Bravaccini S. PMID: 42412051 [PubMed - as supplied by publisher]
	Detection of prostate cancer by magnetic resonance imaging before biopsy - real-world evidence from a nationwide cohort study. Scand J Urol Simoni AH, Ording A, Hedegaard JN, Borre M, Johnsen SP, Møller H. PMID: 42411569 [PubMed - indexed for MEDLINE]
	Diagnostic performance of 18F-prostate-specific membrane antigen-1007 PET/computed tomography and multiparametric MRI in prostate cancer: application of the PRIMARY score in a sub-Saharan African cohort. Nucl Med Commun Loyal PK, Olwit W, Shah J, Mwania M, Makhdomi K, Gitau SN. PMID: 42411249 [PubMed - as supplied by publisher]
	Correlation Between the Natural Course and Magnetic Resonance Imaging Features of Bacillus Calmette-GuÃ©rin-Related Granulomatous Prostatitis in Patients With Bladder Cancer. J Korean Med Sci Sim KC, Sung DJ, Han NY, Han YE, Park BJ, Kim MJ. PMID: 42411237 [PubMed - indexed for MEDLINE]
	Correction to "PruEV-AI: A Simple Approach Combines Urinary Extracellular Vesicle Isolation With AI-Assisted Analysis for Prostate Cancer Diagnosis". Small Methods PMID: 42410940 [PubMed - as supplied by publisher]
	Newly diagnosed high-risk localized prostate cancer after multiple [177Lu]Lu-PSMA radioligand therapy in the context of metastatic parotid carcinoma: a case report. J Med Case Rep Orf C, Handke AE, Noldus J, Roghmann F, Dellino M, Tully KH. PMID: 42410477 [PubMed - in process]
	A comprehensive plasma-based approach to thromboinflammation in bladder cancer: integrating lipidomics, thrombin generation, and NETosis biomarkers. J Transl Med Oto J, Herreros-Pomares A, Verger P, Herranz R, Plana E, Roca M, Pérez-Ardavín J, Vera-Donoso CD, Martínez-Sarmiento M, Bonanad S, Medina P. PMID: 42410426 [PubMed - as supplied by publisher]
	Renal toxicity during VEGF-pathway inhibition in cancer: a practical review of proteinuria, hypertension, and kidney-limited thrombotic microangiopathy. Clin Transl Oncol Corrêa LMA, Lourenço ALM, Brandão LKV, Mazur GR, Barbosa AA, Santiago CBG, Dutra Júnior IF, Husch RG, Delmiro Silva YR, de Santana GC, Dante LE. PMID: 42410275 [PubMed - as supplied by publisher]
	Challenges in postoperative self-management for patients with bladder cancer and urinary stoma: a qualitative study. Support Care Cancer Li Z, Fu Y, Zhang J, Wang Y, Shi T, Yu Q. PMID: 42410042 [PubMed - in process]
	Comparison of DeepSeek-V3.2 and ChatGPT-5.2 in the outpatient diagnosis and treatment of prostate cancer: a multicenter evaluation of application value and multilingual adaptability. Sci Rep Huang C, Wei Y, Xu N, Ju Z, Lin Z, Zhan B, Weng S, Lin R, Yin Y, Lin S, Chen S. PMID: 42409892 [PubMed - as supplied by publisher]
	Prostate-Specific Antigen Screening Patterns and Metastatic Prostate Cancer in US Veterans. JAMA Netw Open Siavoshi M, Frochen S, Fakunle M, Wadhwa A, Green-Lott AY, Bailey AV, Kwan L, Haroldsen C, Effiong A, Rose BS, Rebbeck TR, Iyer HS, Garraway IP. PMID: 42406398 [PubMed - indexed for MEDLINE]
	Next-Generation Checkpoint Combinations: Optimizing PD-(L)1-Based Therapy Across the Advanced, Adjuvant, and Neoadjuvant Settings. Curr Oncol Rep Petrelli F, Colombo Zefinetti L, D'Alessio A, Dottorini L, Ghidini A. PMID: 42406187 [PubMed - indexed for MEDLINE]
	Comparison of MRI-guided in-bore and fusion biopsy for small PI-RADS 4 prostate lesions. World J Urol Zoro, Madendere S, Tar, Veznikli M, Durmaz S, Vural M, Çil BE, Gürses B, Karaarslan U, Esen B, Kordan Y, Tilki D, Esen T. PMID: 42406173 [PubMed - indexed for MEDLINE]
	Sarcopenia is associated with poor survival among patients with non-metastatic renal cell carcinoma and venous tumor thrombus. World J Urol Lahiji R, Esen B, Son LL, Pail D, Koltur C, Mumford S, Schmeusser BN, Luke W, Storino Ramacciotti L, Morton EA, Goodstein TA, Braunschweig A, Nabavizadeh R, Narayan VN, Grajales V, Joshi SS, Hajiha M, Khater N, Ogan K, Psutka SP, Master VA. PMID: 42406172 [PubMed - indexed for MEDLINE]
	Interpretable machine learning model of contrast-enhanced CT radiomics for predicting post-BCG recurrence in high-grade non-muscle-invasive bladder cancer. World J Urol Zou XC, Yu ZJ, Yuan YY, Chao HC, Zeng XJ, Zeng T. PMID: 42406147 [PubMed - indexed for MEDLINE]
	Multimodality staging of renal cell carcinoma-pearls & pitfalls. Abdom Radiol (NY) Withey SJ, Otero-Garcia M, Aymerich M, Baizán-García A, Carnelli C, Robinson E, Hesketh R, Wagner T, Caglic I. PMID: 42406034 [PubMed - as supplied by publisher]
	Risk of second primary cancer after radiotherapy for localized prostate cancer: A single-center Korean cohort study. Investig Clin Urol Bae SH, Byun HJ, Jang HC, Jung W, Ha JY, Kim BH, Byun SJ, Son NH, Shin TJ. PMID: 42405711 [PubMed - indexed for MEDLINE]
	Predictors of benign histology in clinical T1a small renal masses: A large multicenter cohort study. Investig Clin Urol Lee GM, Byun SS, Kwak C, Hwang EC, Kang SH, Chung J, Kim YJ, Ha YS, Hong SH. PMID: 42405710 [PubMed - indexed for MEDLINE]
	Reproducibility of natural-language-driven statistical workflows compared with conventional software for diagnostic metrics in prostate cancer research. Investig Clin Urol Lagos-Beitz HE, Trujillo-Martínez G, González-Quirós CA, Escalante-Armenta R, Martínez-Delgado G, Castillejos-Molina RA, Tena Gonzalez-Mendez G. PMID: 42405709 [PubMed - indexed for MEDLINE]
	An artificial intelligence model integrating clinico-laboratory data and single nucleotide polymorphism-based genomic risk for prostate cancer diagnosis in Korean men. Investig Clin Urol Jung JH, Han GH, So B, Hong M, Ahn SH, Lim SH, Han SM, Park H, Lee SW, Song G, Choi S, Chung HC, Chung H, Kang TW, Eom M, Koh SB, Kim JH. PMID: 42405708 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 179795

Seite 1 von 8990

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung